FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| LEESAR INC | 025104311 | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 20 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| LEESAR INC | 025104311 | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-2 | valid | 2026-08-18 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-08-18 | |
| LEESAR INC | 025104311 | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-400 | 83298-400-05 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-08-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 8 mg/8 mL | 2025-2 | valid | 2026-08-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | 8 mg/8 mL | 2025-2 | valid | 2026-08-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 30 [USP'U]/3 mL | 2025-2 | valid | 2026-08-18 | |
| Medi-Fare Drug | 091326520 | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| Molecular PharmaGroup | 080602630 | 72790-004 | 72790-004-05 | Dehydrated Alcohol | 2.1 mL/3 mL | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-4 | Baclofen | 50 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6705 | 71300-6705-4 | Baclofen | 50 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6631 | 71300-6631-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6564 | 71300-6564-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6727 | 71300-6727-5 | Diclofenac Sodium | 100 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6440 | 71300-6440-2 | Gabapentin | 100 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6630 | 71300-6630-2 | Gabapentin | 100 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6616 | 71300-6616-4 | Ketamine Hydrochloride | 50 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6442 | 71300-6442-2 | Ketoprofen | 100 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6627 | 71300-6627-2 | Ketoprofen | 100 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6676 | 71300-6676-2 | Lidocaine | 75 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6726 | 71300-6726-2 | Lidocaine | 75 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-3 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6635 | 71300-6635-4 | Baclofen | 20 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| Nubratori Inc. | 028707055 | 71300-6706 | 71300-6706-4 | Baclofen | 20 mg/1 g | 2025-2 | valid | 2026-08-18 | |
| OLYMPIA PHARMACY | 017674368 | "nicotinamide-Adenine Dinucleotide Phosphate, Reduced" | 500 mg | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Papaverine Hydrochloride | 3 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Papaverine Hydrochloride | 3 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Phenylephrine Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Proline | 100 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Proline; Lysine Hydrochloride; Arginine Hydrochloride; Citrulline | 50 mg/1 mL; 40.02 mg/1 mL; 100 mg/1 mL; 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Pyridoxine Hydrochloride | 100 g/1 mL | 2025-2 | source_no_ndc | 2026-08-18 | |||
| OLYMPIA PHARMACY | 017674368 | Pyridoxine Hydrochloride | 85 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-18 |